galactosamine has been researched along with deferoxamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tiegs, G; Wendel, A; Werner, C | 1 |
| Isturiz, MA; Meiss, RP; Vulcano, M | 1 |
2 other study(ies) available for galactosamine and deferoxamine
| Article | Year |
|---|---|
Evidence for the involvement of a reperfusion injury in galactosamine/endotoxin-induced hepatitis in mice.
Topics: Allopurinol; Animals; Deferoxamine; Drug Interactions; Endotoxins; Galactosamine; Hepatitis, Animal; Liver; Male; Mice; Perfusion; Salmonella; Vitamin E | 1987 |
Deferoxamine reduces tissue injury and lethality in LPS-treated mice.
Topics: Animals; Deferoxamine; Galactosamine; Interleukin-1; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Tumor Necrosis Factor-alpha | 2000 |